Identification of Serum Interleukin-22 as Novel Biomarker in Pulmonary Hypertension: A Translational Study

Identification of Serum Interleukin-22 as Novel Biomarker in Pulmonary Hypertension: A Translational Study

Growing evidence suggests the crucial involvement of inflammation in the pathogenesis of pulmonary hypertension (PH). The current study analyzed the expression of interleukin (IL)-17a and IL-22 as potential biomarkers for PH in a preclinical rat model of PH as well as the serum levels in a PH patien...

Full description

Bibliographic Details
Main Authors: Friederike Klein, Sandesh Dinesh, Desiree Fiedler, Katja Grün, Andrea Schrepper, Jürgen Bogoviku, Laura Bäz, Alexander Pfeil, Daniel Kretzschmar, P. Christian Schulze, Sven Möbius-Winkler, Marcus Franz
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:International Journal of Molecular Sciences
Subjects:
IL-22
pulmonary hypertension
biomarker
Online Access:https://www.mdpi.com/1422-0067/25/7/3985

Internet

https://www.mdpi.com/1422-0067/25/7/3985

Similar Items